THE MARK CONSISTS OF 4 CHINESE CHARACTERS.

Trademark usage description

allergy relief medication; anti-inflammatory sprays; antibiotic ointments; calcium supplements; diagnostic preparations for medical purposes for detec Read More

Vienna Information

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 22

Quadrilaterals containing other inscriptionsQuadrilatères contenant d'autres inscriptions

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

28 . 3 . 0

Inscriptions in Chinese, Japanese or Korean charactersInscriptions en caractères chinois, japonais ou coréens

Classification Information

Class [005]
Allergy relief medication; anti-inflammatory sprays; antibiotic ointments; calcium supplements; diagnostic preparations for medical purposes for detecting genetic predispositions; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; eye-washes; herbal supplements for general health and well-being; massage gels for pain relief; medicated mouthwash; mineral nutritional supplements; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for wounds; vitamin and mineral preparations; vitamin enriched water for medical use; vitamin supplements in tablet form for making effervescent beverages when added to water

Classification kind code

Mark Details

Serial Number

2115654

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 6 on 7^th Mar 2024	Abandoned - Section 36
Submitted for opposition 14 on 18^th Dec 2023	Default Notice Sent
Submitted for opposition 22 on 31^st May 2023	Search Recorded
Submitted for opposition 20 on 31^st May 2023	Examiner's First Report
Submitted for opposition 48 on 28^th Oct 2021	Agent Changed
Submitted for opposition 30 on 22^nd Jun 2021	Filed
Submitted for opposition 1 on 22^nd Jun 2021	Created
Submitted for opposition 31 on 22^nd Jun 2021	Formalized